Drug intelligence / Profile preview

Shugan Jianwei Wan

Development stage: Unknown
Lead developer: Handan Pharmaceutical
Administration: Oral

Overview

Shugan Jianwei Wan is a Traditional Chinese Medicine (TCM) formula developed and manufactured by Handan Pharmaceutical. It is primarily indicated for the treatment of liver-stomach disharmony, a TCM syndrome pattern characterized by symptoms such as epigastric pain, abdominal distension, acid regurgitation, and loss of appetite. The formula is designed to soothe the liver, regulate Qi, and harmonize the stomach. It is commonly utilized in clinical practice for conditions such as chronic gastritis and functional dyspepsia when they present with the relevant TCM symptoms. The product is an approved pharmaceutical in China and is typically administered as oral pills.

Other names: 舒肝健胃丸Shugan Jianwei Pills

Beyond the preview

Go deeper on Shugan Jianwei Wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shugan Jianwei Wan.

Explore the full profile